4195 Stock Overview
Genomics BioSci & Tech. Co.,Ltd. operates as a genome sequencing company.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 4195 from our risk checks.
Genomics BioSci & Tech. Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$19.05 |
52 Week High | NT$26.08 |
52 Week Low | NT$17.60 |
Beta | 0.26 |
1 Month Change | -0.26% |
3 Month Change | -8.41% |
1 Year Change | -3.33% |
3 Year Change | 21.59% |
5 Year Change | 23.10% |
Change since IPO | -37.85% |
Recent News & Updates
Recent updates
Is Genomics BioSci & Tech. Co.,Ltd.'s (GTSM:4195) 7.2% Dividend Worth Your Time?
Apr 27Key Things To Consider Before Buying Genomics BioSci & Tech. Co.,Ltd. (GTSM:4195) For Its Dividend
Jan 19Genomics BioSci & Tech. Co.,Ltd. (GTSM:4195) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Nov 25Shareholder Returns
4195 | TW Biotechs | TW Market | |
---|---|---|---|
7D | 5.5% | -1.1% | -0.6% |
1Y | -3.3% | -21.5% | 29.2% |
Price Volatility
4195 volatility | |
---|---|
4195 Average Weekly Movement | 2.1% |
Biotechs Industry Average Movement | 4.8% |
Market Average Movement | 4.7% |
10% most volatile stocks in TW Market | 8.7% |
10% least volatile stocks in TW Market | 2.2% |
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | n/a | Kevin Chiang | www.genomics.com.tw |
Genomics BioSci & Tech. Co.,Ltd. operates as a genome sequencing company. It offers regular DNA, complex sequence, and TAF certificated sequencing services, as well as free sequencing primer and primer walking services; peptide, gene, and oligo synthesis services; and sample preparation, gene expression analysis, genotyping analysis, DNA methylation analysis, and microbial identification services.
Genomics BioSci & Tech. Co.,Ltd. Fundamentals Summary
4195 fundamental statistics | |
---|---|
Market cap | NT$1.38b |
Earnings (TTM) | -NT$168.07m |
Revenue (TTM) | NT$396.14m |
3.5x
P/S Ratio-8.2x
P/E RatioIs 4195 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4195 income statement (TTM) | |
---|---|
Revenue | NT$396.14m |
Cost of Revenue | NT$276.23m |
Gross Profit | NT$119.91m |
Other Expenses | NT$287.98m |
Earnings | -NT$168.07m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -2.32 |
Gross Margin | 30.27% |
Net Profit Margin | -42.43% |
Debt/Equity Ratio | 35.1% |
How did 4195 perform over the long term?
See historical performance and comparison